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Brucellosis is an endemic zoonosis in sub-Saharan Africa. pastoralists are at high risk of infection but 
data on brucellosis from these communities are scarce. the study objectives were to: estimate the 
prevalence of human brucellosis, identify the Brucella spp. causing illness, describe non-Brucella 
bloodstream infections, and identify risk factors for brucellosis in febrile patients from a pastoralist 
community of Tanzania. Fourteen (6.1%) of 230 participants enrolled between August 2016 and October 
2017 met study criteria for confirmed (febrile illness and culture positivity or ≥four-fold rise in SAT titre) 
or probable (febrile illness and single SAt titre ≥160) brucellosis. Brucella spp. was the most common 
bloodstream infection, with B. melitensis isolated from seven participants and B. abortus from one. 
Enterococcus spp., Escherichia coli, Salmonella enterica, Staphylococcus aureus and Streptococcus 
pneumoniae were also isolated. Risk factors identified for brucellosis included age and herding, with a 
greater probability of brucellosis in individuals with lower age and who herded cattle, sheep or goats in 
the previous 12 months. Disease prevention activities targeting young herders have potential to reduce 
the impacts of human brucellosis in tanzania. Livestock vaccination strategies for the region should 
include both B. melitensis and B. abortus.
Brucellosis is a globally widespread zoonotic disease1,2, reported as a top ten zoonosis in terms of impact on 
human health and economics of impoverished communities3 and ranking in the top five diseases causing live-
stock losses worldwide4. The Brucella species that most commonly cause human infections are B. melitensis, B. 
abortus, and B. suis1,5. These species are classically associated with small ruminants, cattle, and swine, respec-
tively but transmission between animal hosts is possible6,7. Transmission from animals to people is typically 
via direct contact with infected animals, foodborne transmission, or indirect contact with contaminated envi-
ronments2. Human to human transmission is negligible8. Human brucellosis typically presents as non-distinct 
acute or chronic febrile illness9,10, and is frequently clinically misdiagnosed as other causes of febrile illness, such 
as malaria or typhoid fever10,11. Brucellosis is seldom fatal, but chronic infection is often debilitating and severe 
complications may occur10.
Although not as well recognised as in northern Africa, the Middle East or central Asia, brucellosis is endemic 
in many regions of sub-Saharan Africa12,13. Within pastoral systems where people live in close contact with 
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livestock, there is increased risk of human infection14. Approximately 16% of the population of sub-Saharan 
Africa practice pastoralism. Within Tanzania, it is estimated that up to 40% of the population practices exclu-
sive pastoralism15. As is true regionally, data on brucellosis prevalence and incidence are limited for these 
communities16,17.
Hospital-based febrile surveillance studies of a predominantly urban population in Tanzania, have generated 
prevalence estimates of 3.5% for confirmed brucellosis in 2007–200818 and 8.9% for confirmed or probable bru-
cellosis in 2012–201419 by Brucella microagglutination testing. Serological testing cannot be used for Brucella 
spp. identification20. Brucella spp. can be identified through molecular diagnostic analyses of DNA obtained from 
culture isolates21 or clinical samples, or with phenotypic testing of isolates2. Studies in sub-Saharan Africa that 
have identified the infecting Brucella spp. from human infections are rare6,22. There are no human Brucella spp. 
isolates from Tanzania recorded to date. Livestock isolates from Tanzania are also scarce, but both B. melitensis 
and B. abortus have been isolated, from goats and cattle, respectively23,24. Identification of the Brucella spp. caus-
ing human illness is vital to inform understanding of the most likely animal source population(s) and the design 
of vaccination strategies, as brucellosis vaccines are animal host specific.
Brucella spp. are typically a relatively infrequent cause of human bloodstream infections in sub-Saharan 
Africa as compared to other regions. In sub-Saharan Africa the predominant causes of bloodstream infections 
are Salmonella enterica, Streptococcus pneumoniae, Staphylococcus aureus, and Escherichia coli25,26. Bloodstream 
infection data from communities considered at a high risk of brucellosis within sub-Saharan Africa are scarce.
There are few studies in East Africa that have identified risk factors for acute brucellosis infection as compared 
to Brucella spp. exposure19,27–29. One study, conducted within a largely urban population in Tanzania identified 
assisting in small ruminant births and contact with cattle as risk factors for human brucellosis19. Consumption of 
boiled or pasteurised dairy products was a protective factor19.
To our knowledge, no studies have identified the Brucella spp. responsible for human brucellosis in Tanzania. 
The objectives of this study were to estimate the prevalence of human brucellosis, identify the Brucella spp. caus-
ing human illness, characterise additional causes of bloodstream infections, and identify risk factors for brucello-
sis in febrile hospital patients from a pastoralist community of Tanzania.
Materials and Methods
Study setting and population. The study was conducted at Endulen Hospital in the Ngorongoro 
Conservation Area (NCA), northern Tanzania. The NCA is a multiple land use area of 8,292 km2, designated for 
the pastoralist activities of the local Maasai community, the conservation of wildlife, and tourism30. Livestock 
keeping is ubiquitous among the Maasai. Cattle, sheep, and goats are the predominant livestock species kept and 
are managed extensively in mixed herds30. Endulen Hospital is the only hospital within the NCA. It is a 110-bed 
hospital providing both outpatient and inpatient services to a population of approximately 77,000 persons pre-
dominantly resident within the NCA31.
Study eligibility. All individuals seeking care at the outpatient department of Endulen Hospital were eligible 
for screening, which was integrated into the patient triage processes and performed by Endulen Hospital staff. 
All individuals aged ≥two years with reported fever within the past 72 hours and/or a tympanic temperature 
of ≥38.0 °C at presentation were eligible for enrolment. After initiation of the outpatient visit and routine clin-
ical assessment by Endulen Hospital staff, eligible patients were approached by a member of the study team for 
informed consent to participate in the study.
Sample collection, malaria testing and questionnaire data collection. After cleaning the partic-
ipant’s skin with isopropyl alcohol and povidone iodine, blood was drawn from study participants for culture, 
Brucella serology, and malaria testing. The target blood volume at enrolment was 40 mL, enabling distribution of 
two 10 mL volumes into BacT/ALERT (BioMérieux, Durham, NC, USA) aerobic blood culture bottles for auto-
mated culture, 10 mL into Castañeda media32 (media prepared at the Animal and Plant Health Agency (APHA), 
Weybridge, UK), and 10 mL into a plain vacutainer (BD, Franklin Lakes, NJ, USA) for serology. For study partic-
ipants weighing less than 25 kg, target blood volumes were determined based on weight33 and paediatric BacT/
ALERT bottles were used for automated culture. For all study participants, a fill order algorithm was followed, 
with sample collection prioritised as follows: first automated aerobic blood culture bottle, plain vacutainer, 
Castañeda culture bottle, and second automated aerobic blood culture bottle. Malaria rapid diagnostic testing 
was performed directly from the sample collection syringe using the SD BIOLINE Malaria Ag P.f/Pan rapid diag-
nostic test (Standard Diagnostics/Abbott, Abbott Park, IL, USA) or CareStart Malaria HRP2 (Pf) (ACCESS BIO, 
INC. Somerset, NJ, USA).
A member of the study project team administered a structured, closed-ended questionnaire for each study 
participant (Supplementary Methods). Question topics included: demographic data, symptoms of current and 
recent illness, dietary practices, and animal-related activities. Data collected from study participant clinical 
records included the the initial clinical diagnosis recorded and any drug treatments prescribed on the day of 
hospital presentation (i.e., before any study diagnostic results were available).
All participants were approached for convalescent-phase blood sampling at their homes four to six weeks after 
enrolment. Up to 10 mL blood was collected into a plain vacutainer for convalescent-phase serology.
Blood culture. Inoculated culture bottles were packed for transportation to achieve a target tempera-
ture range of 4–10 °C34. Tinytag Transit 2 Temperature Data Loggers (Gemini Data Loggers Ltd, Chichester, 
UK) were used to monitor transport temperature. Inoculated culture bottles were transferred to the Kilimanjaro 
Clinical Research Institute (KCRI) in Moshi, Tanzania, for laboratory processing the day after inoculation. Time 
and date of inoculation and receipt at the laboratory were recorded. Prior to incubation, the bottom of the BacT/
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ALERT blood culture bottle was visually assessed to confirm no colorimetric change. BacT/ALERT bottles were 
then loaded into the BacT/ALERT 3D instrument and incubated for up to 5 days. Castañeda bottles were incu-
bated in a CO2 incubator at 5–10% CO2 and 37 °C. Bottles were examined for growth every 72 hours for up to 35 
days. For two periods during the study (first from 30 April 2017 to 16 June 2017 inclusive and second from 13 July 
2017 to 30 September 2017 inclusive) BacT/ALERT bottles were also processed by manual culture methods due 
to technical malfunction with the BacT/ALERT system. Standard methods were used for identifying isolates35,36. 
Isolates of gram-negative coccobacilli that had positive reactions for urease, catalase and oxidase were classified 
as presumptive Brucella and stored on Microbank beads (Pro-Lab Diagnostics, Bromborough, UK) at −70 °C. 
Culture bottles were classified as adequately filled if the blood volume added met the supplier’s recommended 
volume +/− 20%. The following organisms were considered likely contaminants: non-anthracis Bacillus spp., 
Corynebacterium spp., Escherichia vulneris, Micrococcus spp., coagulase-negative Staphylococcus spp., viridans 
streptococci. Additionally, Pantoea spp. was identified in three bottles of Castañeda media and was also classified 
as a likely contaminant in our analysis. The results of positive blood culture were shared immediately with the 
clinical team at Endulen Hospital to inform clinical management.
Brucella speciation. Presumptive Brucella spp. isolates were shipped on dry-ice to APHA, UK, for con-
firmatory testing. Identification of Brucella species by culture was performed according to an established typ-
ing scheme37. Crude lysates for use as a template for PCR were prepared by suspending a single colony from 
solid media in 500 µL of nuclease-free water and heating (100 °C for 10 minutes). Molecular confirmation of 
culture-based species typing was performed using multiplex conventional PCR38, quantitative PCR39 and appli-
cation of a nine locus Brucella spp. multilocus sequence typing scheme40,41.
Brucella serology. Filled vacutainer tubes were inverted five times immediately after blood collection and 
kept at ambient temperature for 45–60 minutes to ensure clotting prior to centrifugation at 1300–1500 g for 
10 minutes. Serum was pipetted into cryovials and stored temporarily at 4 °C at Endulen Hospital before being 
transported at 4–10 °C to KCRI. Tinytag Transit 2 Temperature Data Loggers monitored transport temperature 
of serum samples. Sera were stored at −80 °C on arrival at KCRI. Sera were shipped on dry ice to the APHA, for 
serological testing using the Serum Agglutination Test (SAT). Standardised antigen for the detection of antibod-
ies to B. abortus, B. melitensis and B. suis was used (RAA0054, APHA, Weybridge, UK) at a working strength to 
give 50% agglutination with a 1/650 dilution of the International Standard Serum to B. abortus. Samples were 
screened in a microtitre plate at serum dilutions of 1/5, 1/10, 1/20 and 1/40, with total volume per well of 200 µl. 
Any sample showing agglutination in any screening titre was then retested using the tube test format to confirm 
the final titre.
Brucellosis case definition. Brucellosis cases were defined as meeting the study criteria for febrile illness 
of reported fever within the past 72 hours, and/or a tympanic temperature of ≥38.0 °C at hospital presentation, 
plus laboratory evidence of infection. Laboratory evidence of confirmed brucellosis was defined as a blood culture 
positive for Brucella spp. or a four-fold or greater rise in Brucella antibody titre between acute and convalescent 
serum samples. Laboratory evidence of probable brucellosis was defined as a SAT antibody titre of ≥160 in either 
acute or convalescent-phase serum42.
Data management and statistical analyses. A sample size calculation was performed to estimate the 
number of enrolled febrile hospital participants required in order to (i) detect a minimum number of blood 
culture positive individuals and (ii) estimate brucellosis case prevalence (based on culture and serologically iden-
tified cases). Assuming that 3% of presenting febrile individuals would be Brucella blood culture positive as in a 
previous study in Egypt43, it was estimated that a sample of 348 individuals was needed to detect a minimum of 
six Brucella blood culture positive cases with 95% probability. Based on an assumed prevalence of 9%18, it was 
estimated that a sample of 126 individuals would be required to estimate brucellosis case prevalence with preci-
sion of 5% and 80% power.
Data were entered using the OpenText TeleForm system (OpenText, Waterloo, Ontario, Canada) into an 
Access database (Microsoft Corporation, Redmond, WA, USA). Data manipulation and statistical analyses were 
performed using R44. Proportions were reported within exact binomial confidence intervals. Generalised linear 
models were used to evaluate associations between brucellosis case status (positive or negative, combining con-
firmed and probable cases) and clinical data. Univariable logistic regression models were used to investigate pair-
wise associations between brucellosis case status and candidate risk factors for human brucellosis. Questionnaire 
variables were selected for evaluation based on the previously identified or biologically plausible risk factors. 
The following variables were evaluated: age (years), sex, and a series of livestock-related risk variables occur-
ring within the previous 12 months. In each case, livestock refers to cattle, sheep and/or goats. Variables evaluated 
were: assisting livestock parturition, occurrence of livestock abortion or still-born offspring in flock/herd, milking 
livestock, herding livestock, contact with livestock waste (e.g., cleaning animal enclosures or in the construction 
of buildings), slaughtering or butchering livestock, consumption of raw meat (including offal and raw animal 
blood) from cattle, sheep and/or goats, and consumption of raw dairy products from cattle, sheep and/or goats. 
Univariable models were evaluated using likelihood ratio tests (LRT), with a significant p value ≤0.05. Given 
the small number of positive brucellosis cases and high potential for data overfitting, variable selection was per-
formed using lasso regression using the R package glmnet45. Variables retained in the lasso regression were fitted 
in a multivariable logistic regression model and evaluated using LRT. Odds ratios (OR), adjusted odds ratios 
(aOR), and 95% confidence intervals (CI) were estimated.
Research clearance and ethics. Approval to conduct the the study was granted by the Tanzania 
Commission for Science and Technology, Tanzania Wildlife Research Institute and the Ngorongoro Conservation 
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Area Authority. Ethical approval was granted by the Kilimanjaro Christian Medical Centre (KCMC) Ethics 
Committee (698); National Institute of Medical Research (NIMR), Tanzania (NIMR/HQ/R.8c/Vol. I/1140) 
University of Otago Human Ethics Committee (H17/052), and University of Glasgow College of Medical, 
Veterinary and Life Sciences Ethics Committee (200140149). The research was performed in accordance with 
the guidelines and regulations prescribed by the above organisations. Written informed consent for study partic-
ipation was obtained from each participant and/or their legal guardian, using forms translated into Swahili and 
verbal translation into Maa when needed.
Results
From 15 August 2016 to 11 October 2017, 3,473 patients were screened for enrolment into the study. Of the 3,473 
screened patients, 435 (12.5%) were eligible for inclusion in the study. A total of 230 participants enrolled and 
contributed data for the study analyses (Fig. 1).
Blood culture and Brucella speciation. Fourteen (6.1%) of 228 participants with one or more inoculated 
blood culture bottle had a bloodstream infection. Brucella spp. was the most common bloodstream infection. 
Eight (3.5%) of 228 participants were Brucella spp. culture positive. Six other pathogenic bacterial species were 
identified, each in a single participant (Table 1). Brucella spp. isolates from seven (3.0%) participants were identi-
fied as B. melitensis while B. abortus was isolated from one participant (0.4%). The results of molecular speciation 
assays were congruent with phenotyping. Multilocus sequence typing (MLST) identified all seven B. melitensis 
isolates as sequence type (ST) 12, while the single B. abortus isolate was identified as ST32.
In total, 601 culture bottles were inoculated, with one or more bottles inoculated for 228 (98.3%) of 232 partic-
ipants. Of the 601 culture bottles, 531 (88.4%) bottles collected from 215 participants were adequately filled and 
21 (3.5%) of 601 were contaminated. The median time interval between sample collection and processing at the 
laboratory was 25.9 (interquartile range 24.8 to 27.0) hours. A total of 77 (85.0%) of 91 shipments of inoculated 
culture bottles stayed within the target temperature range, all inoculated culture bottles were processed in the 
laboratory. The comparison of Brucella spp. isolation success from adequately filled culture bottle types is given in 
Table 2. Brucella spp. was identified by culture from 16 bottles from the eight culture positive participants, twelve 
of which had adequate fill volumes. Brucella spp. was identified in the Castañeda media bottle for all eight of the 
culture positive individuals. Brucella spp. was identified in one or more of the inoculated BacT/ALERT bottles 
for five of the eight culture positive individuals including adequate and non-adequate fill volumes. The details of 
Brucella spp. isolation success from the individual culture bottles used for the eight Brucella spp. positive indi-
viduals is given in Supplementary Fig. S1.The combination of BacT/ALERT bottles used for participants varied 
throughout the timeline of the study, largely governed by stock and supply variation (Table 2).
Figure 1. Flowchart describing study participant screening, enrolment and data collection steps, Endulen 
Hospital, Tanzania, 2016–2017.
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Brucella serology. Of 232 participants, 230 had acute and/or convalescent serum collected. Paired acute and 
convalescent phase samples were collected for 154 (70.0%) of 230 participants: 70 participants had acute serum 
collected only; and six had convalescent serum only, due to an insufficient blood volume collected at acute hos-
pital presentation. Eleven (4.8%) of 230 participants met the case definition for probable brucellosis with one or 
more SAT antibody titre ≥160. One additional participant met the case definition for confirmed brucellosis based 
on serology data alone, showing a four-fold rise in antibody titre.
Brucellosis case classification. A total of nine (3.9%) of 230 participants met criteria for confirmed bru-
cellosis; eight based on blood culture and one by seroconversion. Six (75.0%) of the eight blood culture positive 
participants had an acute phase SAT titre ≥160, with four of the six also having a convalescent phase SAT titre 
≥160. In total, 14 (6.1%) of 230 participants, met the study definition for a probable or confirmed brucellosis case. 
The correspondence between culture and serology results for study participants and details of the dates of culture 
positives are shown in Supplementary Fig. S2.
participant characteristics, clinical presentation and management. Study participants had a 
median (range) age of 27 (2, 78) years and brucellosis cases had a median (range) age of 11 (7, 20) years. Ten 
(71.4%) of 14 brucellosis cases were male and 13 (92.9%) reported their tribe as Maasai. Of 232 study participants, 
226 (97.4%) reported residence in the NCA with 170 (73.3%) from Endulen village. Residence was also reported 
in the larger Arusha region and adjacent Simiyu region (Fig. 2). All brucellosis cases were participants living 
within the NCA.
Microorganism
Number (%) of 
participants in which 
organism was detected
Brucella spp.
B. melitensis 7 (3.1)
B. abortus 1 (0.4)
Enterococcus spp. 1 (0.4)
Escherichia coli 1 (0.4)
Salmonella enterica 1 (0.4)
Salmonella enterica serovar Typhi 1 (0.4)
Staphylococcus aureus 1 (0.4)
Streptococcus pneumoniae 1 (0.4)
Table 1. Bacterial pathogens recovered from study participants at Endulen Hospital, Tanzania, 2016-2017 (n = 228), 
ordered by frequency of detection.
Bottle pair  
(Bottle A vs Bottle B)
Number of bottles in which Brucella spp. was detected
Bottle A only Bottle B only Both bottles
SA1 vs SA2 0 0 1
SA1 vs FAP1 0 0 0
SA1 vs CAS 0 1 3
SA2 vs CAS 0 0 1
FAP1 vs FAP2 0 0 0
FAP1 vs CAS 0 1 0
FAP2 vs CAS 0 0 0
PF1 vs PF2 0 0 0
PF1 vs PFP 0 0 0
PF1 vs CAS 0 0 0
PF2 vs CAS 0 0 0
PFP vs CAS 0 1 1
Table 2. Comparative Brucella spp. detection from different combinations of culture bottles, including 
adequately filled bottles only (n = 531), Endulen Hospital, Tanzania, 2016–2017. Bottle type abbreviations: 
SA - standard aerobic media; FA - fastidious antimicrobial neutralisation media; FAP - fastidious antimicrobial 
neutralisation plus media; CAS - Castañeda media; PF - paediatric fastidious antimicrobial neutralisation 
media; PFP - paediatric fastidious antimicrobial neutralisation plus media; 1 and 2 numbering indicates the 
order of bottle inoculation when two identical bottle types were filled. For participants ≥25 kg, samples were 
initially inoculated into two SA bottles, which was later adjusted to one SA and one FAP bottle. During periods 
with no supply of SA bottles, two FAP bottles were inoculated. For participants <25 kg, samples were initially 
inoculated into two PF bottles, which was later adjusted to one PF and one PFP bottle.
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The relationship between clinical symptoms and brucellosis case status, as well as details of participant clinical 
management are shown in Table 3. Brucellosis cases were significantly more likely to report night sweats and less 
likely to report back pain as compared to non-cases (Table 3). Brucellosis case status was significantly associated 
with receiving a presumptive diagnosis of brucellosis at hospital presentation (LRT χ2 = 4.82, df = 1, p = 0.03, 
n = 188) and admission to the inpatient ward of the hospital (LRT χ2 = 4.97, df = 1, p = 0.03, n = 191). Sixteen 
(7.0%) of 230 participants, were prescribed a drug regimen consistent with treatment for brucellosis at their initial 
visit. All of the participants treated for brucellosis had a presumptive diagnosis of brucellosis and treatment for 
brucellosis was significantly associated with case status as defined by this study (LRT χ2 = 6.71, df = 1, p = <0.01, 
n = 230). Data on treatment regimens prescribed after the provision of blood culture results (e.g., after the date of 
the initial visit) are not included in our dataset. Six (2.6%) of 230 participants had a test positive for malaria. No 
brucellosis cases were malaria positive.
Risk factors for brucellosis. The univariable associations between the selected risk variables and brucellosis 
case status are shown in Table 4. Risk factor variables significantly associated with brucellosis in febrile hospital 
participants in univariable models were: age of participant (LRT χ2 = 20.05, df = 1, p = <0.01, n = 229), with 
probability of brucellosis declining with increasing age in years; sex (LRT χ2 = 4.76, df = 1, p = 0.03, n = 230), 
with a greater probability of brucellosis in male participants; and herding livestock in the last 12 months (LRT 
χ2 = 14.09, df = 1, p = <0.01, n = 219), with participating in herding cattle, sheep and/or goats associated with 
increased probability of brucellosis. The lasso regression indicated that herding livestock and age variables should 
be retained. Variables significantly associated with brucellosis in febrile hospital participants in the final multi-
variable model were: age of participant (LRT χ2 = 18.17, df = 1, p = <0.01, n = 219), with probability of brucel-
losis declining with increasing age in years; and herding livestock in the last 12 months (LRT χ2 = 11.71, df = 1, 
p = <0.01, n = 219), with participating in herding cattle, sheep and/or goats associated with increased probability 
of brucellosis (Table 4).
Discussion
We found that 3.9% of febrile participants had confirmed brucellosis and 6.1% met critieria for confirmed or 
probable brucellosis in a pastoralist area of Tanzania. Brucella spp. was the most commonly identified blood-
stream infection in this population and both B. melitensis and B. abortus were isolated, with a predominance of B. 
melitensis. Risk factor analysis indicated that young livestock herders were at particular risk of infection.
To our knowledge, this is the first study to characterise bloodstream infections in a pastoralist community 
of Tanzania. Brucella spp. was the most commonly identified bloodstream infection in this population, and this 
contrasts with previous studies which have typically identified Brucella spp. as a relatively rare bloodstream infec-
tion in sub-Saharan Africa25. Several more commonly reported bloodstream infections, including non-typhoidal 
serovars of Salmonella enterica, Staphylococcus aureus, Streptococcus pneumoniae, and Escherichia coli were also 
identified in this study population, but at lower relative frequency as compared to Brucella spp.25,26. Malaria was 
less prevalent than brucellosis in our study participants, as has been reported previously for northern Tanzania46.
Figure 2. Map showing the position of the Ngorongoro Conservation Area (NCA) (blue shading) within 
Arusha region and adjacent to Simiyu region (beige shading), Tanzania. Polygon boundaries are shown for all 
villages within the NCA (blue shading). Green circles show the proportion of enrolled study participants from 
different villages. The white X indicates the location of Endulen Hospital within Endulen village. In the top 
right insert, white polygons show Arusha and Simiyu region locations within an outline map of Tanzania (grey 
shading). Map created using R software version 3.6.144 and the tmap R package60. Shapefiles for administrative 
boundaries from the 2012 census were sourced from the Tanzania National Bureau of Statistics.
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Previous examples of isolation and identification of Brucella spp. in humans within sub-Saharan Africa are 
rare6. Our study identified B. melitensis as the predominant cause of brucellosis, and B. abortus was also identified 
in one participant, confirming the role of both Brucella species as causes of human illness in this setting. The 
Brucella genotypes identified represent sequence types that are almost exclusively associated with Africa, but 
widespread within the continent. B. melitensis ST12 has been identified previously in human cases associated with 
Somalia, Ethiopia, Eritrea, Kenya, Uganda, Nigeria, and Egypt, and in animal infections from Zimbabwe, South 
Africa, and a single Tanzanian livestock isolate47. Fewer isolates of B. abortus ST32 than B. melitensis ST12 have 
been reported from livestock and humans, in Kenya, Chad, and Rwanda47.
The isolation of both B. melitensis and B. abortus indicates that the host species for brucellosis in northern 
Tanzania are likely to include several of the key livestock species kept in this study area, such as cattle, sheep, and 
goats. Camels are not common within the study area. Consistent with the predominance of B. melitensis in this 
study, previous work in the region has identified small ruminants specifically as the most likely sources of human 
Brucella exposure48,49. The NCA is a wildlife conservation area and common species including buffalo (Syncerus 
caffer) and wildebeest (Connachaetes taurinus) are known hosts of Brucella spp.50. Transmission from livestock 
to humans is likely to account for the majority of human infections, but transmission from wildlife to humans in 
this setting cannot be ruled out.
The overall prevalence of brucellosis identified in this study is consistent with the findings of previous febrile 
surveillance studies conducted in Moshi, Tanzania, providing additional evidence of the health impacts of brucel-
losis in northern Tanzania. Using similar diagnostic approaches these previous studies have detected serologically 
confirmed brucellosis at between 3.5% and 6.9%18,19. All confirmed cases in these previous studies were defined 
by seroconversions18,19. In this present study, the majority of confirmed cases were blood culture positive and the 
number and proportion of confirmed cases defined by seroconversion was lower than expected. This difference in 
the ratio of culture to seroconversion-defined confirmed cases may relate to the timing of participant presentation 
at hospital. Brucella spp. isolation is typically more likely early in acute infection21. Confirmation of cases based 
on demonstration of seroconversion is most likely when an acute phase sample is collected very soon after initial 
infection and a convalescent phase sample is also collected several weeks after initial infection. Interestingly, the 
majority of blood culture-confirmed brucellosis cases identified in this study also had acute phase sample SAT 
titre ≥160, indicating that they had already seroconverted by the time of presentation and also had bacteraemia 
that was still detectable by blood culture (Supplementary Fig. S2). The majority of participants in this study lived 
close to Endulen Hospital, whereas earlier studies in Moshi were conducted at a referral hospital18,19. All con-
firmed cases in the previous studies were defined by seroconversion and it is plausible that longer time to pres-
entation explain the absence of culture-confirmed cases in these studies18,19. Two Brucella spp. isolates have been 
obtained from similar ongoing studies in Moshi (Crump JA & Rubach MP, unpublished data). Patients attending 
an urban referral hospital may have had increased access to antimicrobials prior to hospital presentation, again 
Case population 
n/N (%)
Non-case 
population n/N (%) OR (95% CI)
OR p 
value
Symptom
Reported fever in past 
2 weeks 13/14 (92.9) 212/215 (98.6) 0.18 (0.02–3.86) 0.16
Fever type Continuous 0/13 (0.0) 9/211 (0.04) Ref —
Intermittent 13/13 (100) 202/211 (95.8) Inf (-Inf – Inf) 0.99
Unit of fever duration Days 11/13 (84.6) 192/211 (91.0) Ref —
Months 2/13 (15.4) 16/211 (7.58) 2.18 (0.32–9.1) 0.34
Years 0/13 (0.0) 3/211 (1.42) 0.00 (-Inf – Inf) 0.99
Night sweats 13/14 (92.9) 140/210 (66.0) 6.50 (1.26–119.3) 0.07
Fatigue 11/14 (78.6) 192/213 (90.1) 0.40 (0.11–1.87) 0.19
Joint pain 12/14 (85.7) 190/210 (90.5) 0.63 (0.16–4.24) 0.56
Swollen joints 3/14 (21.4) 30/209 (14.4) 1.63 (0.36–5.58) 0.47
Myalgia 5/13 (38.5) 83/201 (41.3) 0.89 (0.26–2.76) 0.84
Back pain 6/14 (42.9) 152 /213 (71.4) 0.30 (0.10–0.90) 0.03
Headache 12/14 (85.7) 185/214 (86.4) 0.93 (0.24–6.24) 0.93
Anorexia 7/14 (50.0) 105/215 (48.8) 1.05 (0.35–3.16) 0.93
Clinical Management
Presumptive 
diagnosis including 
brucellosis
6/13 (46.2) 32/175 (18.3) 3.83 (1.16–12.30) 0.02
Admission to hospital 3/14 (21.4) 7/177 (4.0) 6.62 (1.30–27.75) 0.01
Initial treatment for 
brucellosis 4/14 (28.6) 12/216 (5.6) 6.80 (1.68–23.91) <0.01
Table 3. Clinical symptoms of study participants based on participant report of symptoms experienced during 
current illness, Endulen Hospital, Tanzania, 2016–2017. Reported % reflects the denominator appropriate for 
each symptom. Univariable analysis odds ratio (OR), 95% confidence intervals (CI) and p values are given. OR, 
CI and p values reported to two decimal places.
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reducing chances of positive culture. Additionally, our study was designed to preferentially detect acute brucel-
losis in acutely febrile individuals seeking healthcare, and is thus less likely to detect chronic brucellosis cases. It 
has been estimated that 40% of brucellosis cases may persist with chronic disease for two years following disease 
onset, and 10% may persist with clinical manifestations after six years51. Further investigations of the combined 
health impacts of acute and chronic human brucellosis in this population are warranted to evaluate the combined 
burden of disease52.
Risk factors associated with brucellosis in the univariable models in this study included younger age, male sex 
and herding livestock. Lasso regression selected herding livestock and age variables, which were retained for the 
multivariable model. The fact that the sex variable was not retained in the final model is likely to be due to cor-
relation between male sex and having herded livestock. Higher risk of Brucella spp. exposure at an early age has 
been recognised for nomadic groups, with adults often more likely suffering from chronic brucellosis infection2. 
Within the largely Maasai community of the NCA, young boys are preferentially given responsibility for herding 
livestock (RFB personal communication during NCA community meetings). Herding can involve multiple activ-
ities that may put individuals at higher risk of exposure to Brucella spp. as well as many other zoonotic pathogens. 
These activities may include: frequent contact with livestock, assisting in animal parturition, butchering livestock 
and consuming specific organs raw or eating undercooked meat and blood53, and drinking raw milk directly 
from animals in the herd or flock53. Some of the more common risk factors for human brucellosis reported in 
East Africa such as: consumption of raw animal products27,54, assisting in animal parturition events and contact 
with aborted animal materials31,55,56 and slaughtering57 were not identified in this study. The small number of 
brucellosis cases identified and the high proportions of the study population participating in perceived high risk 
activities, complicate efforts to disentangle the relative importance of specific risk activities and transmission 
pathways in this population. Further investigation into activities conducted whilst herding that may increase 
exposure to Brucella spp. may identify additional specific risk factors for infection in the young herders identified 
as high risk in our study.
Diagnosis of brucellosis by clinical symptoms alone is unreliable due to varying clinical manifestations of 
infection10. In the present study brucellosis case status was positively associated with night sweats but negatively 
associated with back pain. These findings reinforce the challenges of using clinical symptoms for brucellosis case 
identification. In spite of this, brucellosis was a relatively common presumptive diagnosis made by clinicians at 
the Endulen Hospital, indicating high clinical awareness of the disease in this setting. There was also a significant 
association between presumptive diagnosis of brucellosis and brucellosis case status. Not all participants with 
a presumptive diagnosis of brucellosis were started on a brucellosis consistent treatment on the day of hospital 
presentation. However, the data presented on treatments refer to treatments prescribed at initial presentation 
only and do not capture later decisions based on additional findings, including the subsequent blood culture 
results provided through the study. Overall, these data highlight the challenges faced by clinicians in areas where 
brucellosis is endemic but access to high quality diagnostics including blood culture and SAT serology is limited. 
There is a need for improved diagnostic tools and diagnostic guidelines for the management of acute brucellosis 
and febrile illness more generally in Tanzania, and East Africa more widely11.
Brucellosis has been identified as one of six priority zoonotic diseases in Tanzania58, prompting the develop-
ment of a national strategy for brucellosis prevention and control in humans and animals59. These study findings, 
including human prevalence estimates, identification of both B. melitensis and B. abortus as causes of human 
illness and risk factors for acute human illness, can inform the development of evidence-based control strategies 
for brucellosis in Tanzania.
Variable
Case population
n/N (%)
Non-case population
n/N (%)
Univariable Univariable Multivariable Multivariable
OR (95% CI) OR p value aOR (95% CI) aOR p value
Age (years) 0.89 (0.83, 0.95) <0.01 0.88 (0.81, 0.94) <0.01
Sex
Female 4/14 (28.6) 126/216 (58.3) Ref —
Male 10/14 (71.4) 90/216 (41.7) 3.50 (1.13, 13.08) 0.04
Assisted in livestock parturition 3/14 (21.4) 54/213 (25.4) 0.80 (0.18, 2.69) 0.74
Livestock abortion or still-born 
offspring in herd/flock 8/12 (66.7) 80/203 (65.0) 3.08 (0.94, 11.83) 0.07
Milked livestock 8/14 (57.1) 75/211 (35.5) 2.42 (0.81, 7.59) 0.11
Herded livestock 12/14 (85.7) 73/205 (35.6) 10.85 (2.86, 70.95) <0.01 10.16 (2.49, 69.75) <0.01
Contact with livestock waste 7/14 (50.0) 112/214 (52.3) 0.91 (0.30, 2.75) 0.87
Slaughtered or butchered livestock 9/14 (64.3) 175/213 (82.2) 0.39 (0.13, 1.33) 0.11
Consumed raw meat, offal or animal blood 4/14 (28.6) 56/215 (26.0) 1.14 (0.30, 3.55) 0.84
Consumed raw dairy products 7/14 (50.0) 55/215 (26.0) 2.91 (0.96, 8.86) 0.06
Table 4. Univariable and multivariable risk factor analyses for brucellosis case status among febrile hospital 
participants, Endulen Hospital, Tanzania, 2016–2017. Odds ratios (OR), adjusted odds ratios (aOR), 95% 
confidence intervals (CI) and p values are shown. OR, aOR, CI and p values reported to two decimal places. 
The term livestock refers to cattle, sheep and/or goats. Consumption practices also refer to products from cattle, 
sheep or goats. The period of reference for all livestock variables was the previous 12 months.
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conclusions
We found that brucellosis was the cause of 6.1% of febrile illness among study participants presenting for out-
patient hospital care, and that Brucella spp. are the most commonly identified bloodstream infection in this pre-
dominantly pastoralist community from the NCA, Tanzania. Our findings show that human brucellosis is caused 
by both B. melitensis and B. abortus consistent with transmission from multiple livestock host species. Within 
this pastoralist community, young livestock herders are at high risk of brucellosis infection. Brucellosis control 
activities in Tanzania which focus on prevention of transmission to individuals at high risk of infection, and live-
stock vaccination campaigns directed at both cattle and small ruminants have potential for substantial impacts in 
reducing human brucellosis risk.
Data availability
The datasets generated during and/or analysed during the current study are available in the Enlighten research 
data repository of the University of Glasgow (http://dx.doi.org/10.5525/gla.researchdata.978). The sequence 
typing data for the isolates from this study are available in the Brucella MLST Databases https://pubmlst.org/
brucella/.
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